Stock screenerAll disclosures → EDGAR →
CELZ
Conviction 0FinancialsScan · Mon, Jul 20, 2026CELZ$0.8599-2.17%
ResistanceSupportVol 14Vol MA14 14.3M
Apr 20May 6May 26Jun 11Jul 1Jul 20
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.creativemedicaltechnology.com ↗
Price0.8599
Change-2.17%
Gap+3.08%
Rel volume0.01×
Avg volume10.13M
Avg $ vol14.48M
SMA 201.20
SMA 501.82
SMA 2002.27
Price vs 50-52.78%
Price vs 200-62.20%
MA stackbearish
50/200 cross—
Supertrenddown · 1.56
RSI (14)31
MACD hist-0.00
MACD cross—
Stoch %K / %D1 / 2
ADX (14)28
+DI / −DI42 / 24
RSI divergence—
MACD divergence—
ATR %+28.86%
ADR %24.78%
52w high5.59
52w low0.8102
From 52w high-84.62%
Above 52w low+6.13%
New 52w highNo
SqueezeOff
Bollinger width140.22%
%B0.30
Donchian pos1.78%
Donchian high4.72
Donchian low0.7901
AVWAP (52w high)2.43
vs AVWAP high-64.57%
AVWAP (52w low)2.43
vs AVWAP low-64.55%
OBV trendUp
Chaikin MF (20)-0.91
Today vs 20d0.01×
Avg vol (14d)14.3M
Avg vol (20d)10.13M
Avg $ vol (20d)14.48M
Market cap3.18M
RS 3m (vs SPY)-68.21%
RS 6m (vs SPY)-60.15%
RS line new highNo
Trend template0/8
Technical rank7.5
1 week+0.66%
1 month-61.61%
3 months-65.19%
6 months-54.74%
1 year-67.18%
YTD-56.35%
P/E-0.53
P/B0.52
P/S529.79
P/FCF—
EPS-2.52
Div yield—
ROE-98.12%
ROA-93.08%
Debt/Eq0.84
Current19.69
EV/EBITDA-0.63
Gross margin63.43%
Net margin—
Rev growth-45.45%
EPS growth-9.13%
Price target20.00
Target upside2225.85%
Analyst ratingBuy
Institutional2.75%
Ent. value3.82M
Revenue0
Net income-1.41M
Gross profit0
Free cash flow—
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out3.7M
Employees4
ListedThu, Apr 30, 2009
Free float3.66M
Float %99.1%
Short interest602.28K
Days to cover0.0d
Short volume41.0%
Squeeze score34 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.38 vs −$0.39
Last surprise+2.6% beat
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank7.5 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.61
Support0.7961
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CELZ
No recent disclosed trades by Congress in CELZ. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CELZ
No recent insider (Form 4) filings in CELZ. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in CELZ · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.